Endometrial Cancer Clinical Trials in L'Hospitalet de Llobregat, Barcelona
2 recruitingL'Hospitalet de Llobregat, Barcelona, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Endometrial Cancer
Merck Sharp & Dohme LLC1,123 enrolled232 locationsNCT06952504
Recruiting
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
Endometrial Cancer
MiMARK Diagnostics, S.L.3,000 enrolled2 locationsNCT07148154